Evidence – Leveraging Digital Pathology & AI to Improve Translational Decision-Making in Oncology

• Applying digital pathology and AI-driven image analysis to generate deeper insights into tumour biology, therapeutic response, and biomarker expression
• Integrating pathology, imaging, and translational datasets to improve confidence in development decisions and patient stratification strategies
• Understanding how computational pathology can accelerate biomarker discovery and support more predictive oncology research

Speakers:

Monika Lamba Saini

Director, Medical, Translational, & Computational Pathology

GlaxoSmithKline